Pivotal Bioventure Partners Investment Advisor Llc Portfolio Stock Holdings
Pivotal Bioventure Partners Investment Advisor Llc disclosed 13 stock positions valued at approximately $279.8 million in its latest SEC 13F filing. The largest holdings include VAXCYTE INC, OCULIS HOLDING AG, and ARCUTIS BIOTHERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 13
- Portfolio Value
- $279.8M
Holdings by Sector
Pivotal Bioventure Partners Investment Advisor Llc Portfolio Holdings in Q1 2026
7 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| VAXCYTE INC | PCVX | Healthcare | 28.51% | 1,372,425 | - | - | $79,751,617 |
| OCULIS HOLDING AG | H5870P102 | Other | 15.97% | 1,680,283 | -608,375 | -26.58% | $44,678,725 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 11.42% | 1,355,892 | -10,732 | -0.79% | $31,944,816 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 6.63% | 1,553,726 | +296,944 | +23.63% | $18,535,951 |
| IMMUNOME INC | IMNM | Healthcare | 5.73% | 732,512 | - | - | $16,020,037 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 1.58% | 295,933 | +295,933 | +100.00% | $4,418,280 |
| RECURSION PHARMACEUTICALS IN | RXRX | Healthcare | 0.65% | 595,518 | - | - | $1,828,240 |